Clifford R. Jack
Department of Radiology
Mayo Clinic and Foundation
Rochester
MN
Name/email consistency: high
- An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Jack, C.R., Knopman, D.S., Weigand, S.D., Wiste, H.J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J.L., Senjem, M.L., Ivnik, R.J., Roberts, R.O., Rocca, W.A., Boeve, B.F., Petersen, R.C. Ann. Neurol. (2012)
- Age-related changes in the default mode network are more advanced in Alzheimer disease. Jones, D.T., Machulda, M.M., Vemuri, P., McDade, E.M., Zeng, G., Senjem, M.L., Gunter, J.L., Przybelski, S.A., Avula, R.T., Knopman, D.S., Boeve, B.F., Petersen, R.C., Jack, C.R. Neurology (2011)
- Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Jack, C.R., Wiste, H.J., Vemuri, P., Weigand, S.D., Senjem, M.L., Zeng, G., Bernstein, M.A., Gunter, J.L., Pankratz, V.S., Aisen, P.S., Weiner, M.W., Petersen, R.C., Shaw, L.M., Trojanowski, J.Q., Knopman, D.S. Brain (2010)
- Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Jack, C.R., Bernstein, M.A., Borowski, B.J., Gunter, J.L., Fox, N.C., Thompson, P.M., Schuff, N., Krueger, G., Killiany, R.J., Decarli, C.S., Dale, A.M., Carmichael, O.W., Tosun, D., Weiner, M.W. Alzheimers. Dement (2010)
- Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Jack, C.R., Lowe, V.J., Weigand, S.D., Wiste, H.J., Senjem, M.L., Knopman, D.S., Shiung, M.M., Gunter, J.L., Boeve, B.F., Kemp, B.J., Weiner, M., Petersen, R.C. Brain (2009)
- 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Jack, C.R., Lowe, V.J., Senjem, M.L., Weigand, S.D., Kemp, B.J., Shiung, M.M., Knopman, D.S., Boeve, B.F., Klunk, W.E., Mathis, C.A., Petersen, R.C. Brain (2008)
- The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. Jack, C.R., Bernstein, M.A., Fox, N.C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P.J., L Whitwell, J., Ward, C., Dale, A.M., Felmlee, J.P., Gunter, J.L., Hill, D.L., Killiany, R., Schuff, N., Fox-Bosetti, S., Lin, C., Studholme, C., DeCarli, C.S., Krueger, G., Ward, H.A., Metzger, G.J., Scott, K.T., Mallozzi, R., Blezek, D., Levy, J., Debbins, J.P., Fleisher, A.S., Albert, M., Green, R., Bartzokis, G., Glover, G., Mugler, J., Weiner, M.W. J. Magn. Reson. Imaging (2008)
- Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Jack, C.R., Petersen, R.C., Grundman, M., Jin, S., Gamst, A., Ward, C.P., Sencakova, D., Doody, R.S., Thal, L.J. Neurobiol. Aging (2008)
- Atrophy rates accelerate in amnestic mild cognitive impairment. Jack, C.R., Weigand, S.D., Shiung, M.M., Przybelski, S.A., O'Brien, P.C., Gunter, J.L., Knopman, D.S., Boeve, B.F., Smith, G.E., Petersen, R.C. Neurology (2008)
- Magnetic resonance imaging research in aging and dementia at the Mayo Clinic. Jack, C.R. Alzheimer. Dis. Assoc. Disord (2008)
- Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research. Jack, C.R., Marjanska, M., Wengenack, T.M., Reyes, D.A., Curran, G.L., Lin, J., Preboske, G.M., Poduslo, J.F., Garwood, M. Neuroscientist (2007)
- Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Jack, C.R., Shiung, M.M., Weigand, S.D., O'Brien, P.C., Gunter, J.L., Boeve, B.F., Knopman, D.S., Smith, G.E., Ivnik, R.J., Tangalos, E.G., Petersen, R.C. Neurology (2005)
- In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. Jack, C.R., Wengenack, T.M., Reyes, D.A., Garwood, M., Curran, G.L., Borowski, B.J., Lin, J., Preboske, G.M., Holasek, S.S., Adriany, G., Poduslo, J.F. J. Neurosci. (2005)
- Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Jack, C.R., Shiung, M.M., Gunter, J.L., O'Brien, P.C., Weigand, S.D., Knopman, D.S., Boeve, B.F., Ivnik, R.J., Smith, G.E., Cha, R.H., Tangalos, E.G., Petersen, R.C. Neurology (2004)
- In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Jack, C.R., Garwood, M., Wengenack, T.M., Borowski, B., Curran, G.L., Lin, J., Adriany, G., Gröhn, O.H., Grimm, R., Poduslo, J.F. Magn. Reson. Med (2004)
- Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease. Kantarci, K., Jack, C.R. NeuroRx (2004)
- MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Jack, C.R., Slomkowski, M., Gracon, S., Hoover, T.M., Felmlee, J.P., Stewart, K., Xu, Y., Shiung, M., O'Brien, P.C., Cha, R., Knopman, D., Petersen, R.C. Neurology (2003)
- FLAIR histogram segmentation for measurement of leukoaraiosis volume. Jack, C.R., O'Brien, P.C., Rettman, D.W., Shiung, M.M., Xu, Y., Muthupillai, R., Manduca, A., Avula, R., Erickson, B.J. J. Magn. Reson. Imaging (2001)
